✦ LIBER ✦

The use of botulinum toxin in benign prostatic hyperplasia

✍ Scribed by Cristobal Marchal; Juan E. Perez; Bernardo Herrera; Francisco J. Machuca; Maximino Redondo

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 97 KB
Volume: 31
Category: Article
ISSN: 0733-2467
DOI: 10.1002/nau.21142

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical assessment of benign prosta

The clinical assessment of benign prostatic hyperplasia

✍ Roger S. Kirby 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 734 KB

Benign prostatic hyperplasia. The scope

Benign prostatic hyperplasia. The scope of the problem

✍ John T. Grayhack 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB 👁 2 views

An appraisal of telomerase activity in b

An appraisal of telomerase activity in benign prostatic hyperplasia

✍ E. Caldarera; N.H. Crooks; G.H. Muir; M. Pavone-Macaluso; P.L. Carmichael 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 2 views

## Background: Prostate cancer is one of the commonest neoplasms in elderly males in developed countries. it is not clear which individuals are at high risk of developing aggressive adenocarcinoma of the prostate. biomarkers are therefore urgently needed to identify such individuals. it had been su

The association of benign prostatic hype

The association of benign prostatic hyperplasia and cancer of the prostate

✍ David G. Bostwick; William H. Cooner; Louis Denis; George W. Jones; Peter T. Sca 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 976 KB

α-Adrenergic approach in the medical man

α-Adrenergic approach in the medical management of benign prostatic hyperplasia

✍ Péter Mátyus; Katalin Horváth 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

DNA fingerprint detection of somatic mut

DNA fingerprint detection of somatic mutations in benign prostatic hyperplasia and prostatic adenocarcinoma

✍ Cedric J. Werely; Christiaan F. Heyns; Dirk J. J. Van Velden; Paul D. Van Helden 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

Genetic alterations within diseased prostate tissue were analysed by genomic DNA fingerprinting using a minisatellite probe (lambda 33.6), a simple repetitive oligonucleotide probe (GTG),, and an additional human multilocus probe (pV47-2). In prostatic adenocarcinoma, somatic mutations were detected